keyword
https://read.qxmd.com/read/38652538/hepatic-hif2-is-a-key-determinant-of-manganese-excess-and-polycythemia-in-slc30a10-deficiency
#1
JOURNAL ARTICLE
Milankumar Prajapati, Jared Z Zhang, Lauren Chiu, Grace S Chong, Courtney J Mercadante, Heather L Kowalski, Bradley S Delaney, Jessica A Anderson, Shuling Guo, Mariam Aghajan, Thomas B Bartnikas
Manganese is an essential yet potentially toxic metal. Initially reported in 2012, mutations in SLC30A10 are the first known inherited cause of manganese excess. SLC30A10 is an apical membrane protein that exports manganese from hepatocytes into bile and from enterocytes into the lumen of the gastrointestinal tract. SLC30A10 deficiency results in impaired gastrointestinal manganese excretion, leading to manganese excess, neurologic deficits, liver cirrhosis, polycythemia, and erythropoietin excess. Neurologic and liver disease are attributed to manganese toxicity...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652392/statewide-survey-of-primary-care-and-subspecialty-providers-on-hepatocellular-carcinoma-risk-stratification-and-surveillance-practices
#2
JOURNAL ARTICLE
Andrew M Moon, Rachel M Swier, Lindsay M Lane, A Sidney Barritt, Hanna K Sanoff, Andrew F Olshan, Stephanie B Wheeler, George N Ioannou, Nicole J Kim, Scott Hagan, Philip Vutien, Thad Benefield, Louise M Henderson
BACKGROUND: Hepatocellular carcinoma (HCC) surveillance in patients with cirrhosis is associated with improved survival. Provision of HCC surveillance is low in the US, particularly in primary care settings. AIMS: To evaluate current hepatitis C virus (HCV) and HCC surveillance practices and physician attitudes regarding HCC risk-stratification among primary care and subspecialty providers. METHODS: Using the Tailored Design Method, we delivered a 34-item online survey to 7654 North Carolina-licensed internal/family medicine or gastroenterology/hepatology physicians and advanced practice providers in 2022...
April 23, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38652390/a-prospective-multimodal-education-intervention-for-providers-does-not-increase-hepatic-encephalopathy-treatment-rates
#3
JOURNAL ARTICLE
Patrick A Twohig, Thoetchai Bee Peeraphatdit, Kaeli Samson, Makayla Schissel, Lynette Smith, Allison Ashford, Laura Freese, Timothy McCashland
BACKGROUND: Over 50% of hospitalizations from hepatic encephalopathy (HE) are preventable, but patients often do not receive medical treatment. AIMS: To use a multimodal education intervention (MMEI) to increase HE treatment rates and to evaluate (1) trends in HE treatment, (2) predictors of receiving treatment, and (3) the impact of treatment on hospitalization outcomes. METHODS: Prospective single-center cohort study of patients hospitalized with HE from April 1, 2020-September 30, 2022...
April 23, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38651202/detection-of-significant-liver-fibrosis-in-chinese-psoriasis-patients-receiving-methotrexate-a-comparison-between-transient-elastography-and-liver-histology
#4
JOURNAL ARTICLE
C S M Wong, L L Y Mak, V K H Lee, R C L Lo, M M H Chung, F Chu, C K Yeung, M F Yuen, H H L Chan
INTRODUCTION: Methotrexate (MTX) is effective for treating psoriasis and psoriatic arthritis, but its potential hepatoxicity remains a concern. Liver biopsy, the gold standard for detecting MTX-induced liver injury, is invasive and carries considerable risk. Transient elastography (TE) offers a non-invasive alternative for detecting advanced liver fibrosis. This study investigated the performance of TE in detecting MTX-induced liver fibrosis among Chinese psoriasis patients, compared with liver biopsy...
April 2024: Hong Kong Medical Journal
https://read.qxmd.com/read/38651137/hepatitis-c-virus-antiviral-drug-resistance-and-salvage-therapy-outcomes-across-australia
#5
JOURNAL ARTICLE
Dao Sen Wang, Amy Phu, Kristen McKee, Simone I Strasser, Sinead Sheils, Martin Weltman, Sue Sellar, Joshua S Davis, Mel Young, Alicia Braund, Geoffrey C Farrell, Anne Blunn, Damian Harding, Lucy Ralton, Kate Muller, Scott A Davison, David Shaw, Marnie Wood, Krispin Hajkowicz, Richard Skolen, Jane Davies, Jaclyn Tate-Baker, Adam Doyle, Rhoda Tuma, Simon Hazeldine, Wendy Lam, Natalie Edmiston, Krista Zohrab, William Pratt, Belinda Watson, Amany Zekry, Carlie Stephens, Paul J Clark, Melany Day, Gordon Park, Hami Kim, Mark Wilson, Bruce McGarity, Natalie Menzies, Darren Russell, Thao Lam, Peter Boyd, Jen Kok, Jacob George, Mark W Douglas
BACKGROUND: Hepatitis C virus (HCV) infection can now be cured with well-tolerated direct-acting antiviral (DAA) therapy. However, a potential barrier to HCV elimination is the emergence of resistance-associated substitutions (RASs) that reduce the efficacy of antiviral drugs, but real-world studies assessing the clinical impact of RASs are limited. Here, an analysis of the impact of RASs on retreatment outcomes for different salvage regimens in patients nationally who failed first-line DAA therapy is reported...
April 2024: Open Forum Infectious Diseases
https://read.qxmd.com/read/38651030/alcoholism-and-socioeconomic-status-among-patients-with-hepatic-encephalopathy-in-association-with-increased-mortality
#6
JOURNAL ARTICLE
Prabhudas Nelaturi, Sangeetha P Kadamani, Ravikumar Sambandam
BACKGROUND: Hepatic encephalopathy (HE) is a complex neuropsychiatric disorder indicated by a deterioration in the functioning of hepatocytes. Impaired brain function is observed in advanced alcoholic liver disease particularly manifesting as HE. The pathophysiology of alcohol-related HE remains unclear. Accordingly, this study aimed to assess alcoholism and socioeconomic status of patients with liver disease compared with stages of HE. METHODS: This cross-sectional study was conducted on 62 alcoholic patients who have been consuming alcohol for more than 14 years...
February 2024: Addiction & Health
https://read.qxmd.com/read/38651006/correlation-analysis-of-il-17-il-21-il-23-with-non-alcoholic-liver-fibrosis-and-cirrhosis
#7
JOURNAL ARTICLE
Xiaoyan Yang, Liyin Liao, Zizhen Liang, Shenglong Yu, Zhonghui Guo
OBJECTIVE: This research aimed to explore the involvement of interleukins (IL) - IL-6, IL-17, IL-21, and IL-23 - in the evolution and diagnosis of non-alcoholic liver fibrosis and cirrhosis. METHODS: The study subjects were selected from the patients who visited the Department of Hepatology of X Hospital in Y City from August 2021 to April 2023. Peripheral blood samples were collected. All participants were divided into liver fibrosis, cirrhosis, hepatitis, and healthy subjects four groups...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38650735/isolation-of-mucosa-associated-microbiota-dysbiosis-in-the-ascending-colon-in-hepatitis-c-virus-post-sustained-virologic-response-cirrhotic-patients
#8
JOURNAL ARTICLE
Yohei Midori, Takuto Nosaka, Katsushi Hiramatsu, Yu Akazawa, Tomoko Tanaka, Kazuto Takahashi, Tatsushi Naito, Hidetaka Matsuda, Masahiro Ohtani, Yasunari Nakamoto
BACKGROUND: Achieving sustained virologic response (SVR) in patients infected with hepatitis C virus (HCV) reduces all-cause mortality. However, the mechanisms and risk factors for liver fibrosis and portal hypertension post-SVR remain incompletely understood. In the gut-liver axis, mucosa-associated microbiota (MAM) substantially influence immune and metabolic functions, displaying spatial heterogeneity at the anatomical intestinal site. We analyzed MAM composition and function to isolate the locoregional MAM involved in chronic liver disease progression in HCV post-SVR patients...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38649284/modest-effect-of-differential-dietary-vitamin-a-intake-on-the-pathogenesis-of-alcohol-associated-liver-disease
#9
JOURNAL ARTICLE
Afroza Ferdouse, Robin D Clugston
BACKGROUND: Chronic alcohol consumption is a major public health issue. The primary organ damaged by alcohol abuse is the liver, leading to alcohol-associated liver disease (ALD). ALD begins with hepatic steatosis and can progress to fibrosis and cirrhosis; however, we have an incomplete understanding of ALD pathogenesis. Interestingly, the liver is also the major organ for vitamin A metabolism and storage, and ALD has previously been linked with altered hepatic vitamin A homeostasis...
April 22, 2024: Alcohol Clin Exp Res (Hoboken)
https://read.qxmd.com/read/38649216/hepato-cardio-renal-syndrome
#10
REVIEW
Abhilash Koratala, Frederik Verbrugge, Amir Kazory
Hepatorenal syndrome has conventionally been regarded as a multisystem syndrome in which pathophysiologic pathways that link cirrhosis with impairment in kidney function are followed by dysfunction of several organs such as the heart. The advances in cardiac studies have helped diagnose more subtle cardiac abnormalities that would have otherwise remained unnoticed in a significant subset of patients with advanced liver disease and cirrhosis. Accumulating data suggests that in many instances, the cardiac dysfunction precedes and predicts development of kidney disease in such patients...
March 2024: Adv Kidney Dis Health
https://read.qxmd.com/read/38649215/cholemic-nephropathy-role-in-acute-kidney-injury-in-cholestasis-and-cirrhosis
#11
REVIEW
Klemens Pinter, Alexander Rosenkranz
The concept of structural kidney damage and renal dysfunction as a result of jaundice attracted attention in the medical community in the early and mid-20th century. The postulated doctrine of the time was that the excretion of elevated concentrations of bile results in bile-stained casts occupying collecting and distal convoluted tubules, degeneration of tubular epithelium, and decreased renal function. Compared to the hepatorenal syndrome, the poster child of hepatology and nephrology collaboration, the notion of structural kidney damage and renal dysfunction as a result of cholemia lost its traction and has almost disappeared from modern textbooks...
March 2024: Adv Kidney Dis Health
https://read.qxmd.com/read/38647617/spontaneous-clearance-of-serum-hcv-rna-after-splenectomy-in-a-patient-with-hcv-related-liver-cirrhosis-and-portal-hypertension-a-case-report
#12
JOURNAL ARTICLE
Toshiro Ogata, Terufumi Sakai, Sho Shibata, Hiroki Kanno, Hiroyuki Nakane, Takeshi Aoyagi, Kazuhiro Koikawa, Yoshihiko Sadakari, Gentaro Hirokata, Masahiko Taniguchi
BACKGROUND: Spontaneous clearance of chronic hepatitis C virus (HCV) is rare in adults. A T-lymphocyte response is thought to be involved in HCV-RNA clearance. Splenectomy reportedly has a beneficial effect on T cell immune function in patients with cirrhosis. To the best of our knowledge, the present report is the first to describe spontaneous clearance of serum HCV-RNA within 1 year after splenectomy in a patient with cirrhosis. CASE PRESENTATION: A 55-year-old man with HCV cirrhosis was transferred to our institution with advanced pancytopenia, splenomegaly, and gastric varices...
April 22, 2024: Surgical Case Reports
https://read.qxmd.com/read/38646627/love-hate-relationship-between-hepatitis-b-virus-and-type-2-diabetes-a-mendelian-randomization-study
#13
JOURNAL ARTICLE
Yunfeng Yu, Keke Tong, Gang Hu, Xinyu Yang, Jingyi Wu, Siyang Bai, Rong Yu
OBJECTIVE: The impact of hepatitis B virus (HBV) on the risk of type 2 diabetes (T2D) remains a controversial topic. This study aims to analyze the causal relationship between HBV and T2D using Mendelian randomization (MR). METHODS: Single nucleotide polymorphisms on chronic hepatitis B (CHB), liver fibrosis, liver cirrhosis, and T2D were obtained from BioBank Japan Project, European Bioinformatics Institute, and FinnGen. Mendelian randomization was utilized to evaluate exposure-outcome causality...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38644553/narrative-review-of-malignant-ascites-epidemiology-pathophysiology-assessment-and-treatment
#14
JOURNAL ARTICLE
Takako Ikegami, Hiroto Ishiki, Toru Kadono, Tetsuya Ito, Naosuke Yokomichi
BACKGROUND AND OBJECTIVE: Malignant ascites (MA) is common in patients with advanced cancer, and about 60% of patients with MA experience distressing symptoms. In addition, MA has been identified as a poor prognostic factor, therefore, making the management of MA an important issue. We aimed to review literature describing MA provide a narrative synthesis of relevant studies. METHODS: A literature search of articles published between 1971 and May 2023 was performed in PubMed, and Cochrane library using the words "ascites/malignant ascites" and the theme of each section...
April 18, 2024: Annals of Palliative Medicine
https://read.qxmd.com/read/38643819/elevated-serum-he4-levels-as-a-novel-biomarker-of-disease-severity-and-hepatic-fibrosis-in-autoimmune-hepatitis
#15
JOURNAL ARTICLE
Zhi Yu, Caina Nian, Wenmei Sun, Xinhua Liu, Xueyuan Nian
BACKGROUND: Human epididymis protein 4 (HE4) has been identified as a biomarker for renal fibrosis. This study aimed to evaluate the role of HE4 in the diagnosis and determination of disease severity and hepatic fibrosis in autoimmune hepatitis (AIH). METHODS: Serum HE4 levels were determined via electrochemiluminescence immunoassays in 60 healthy controls and 109 AIH patients (43 without liver cirrhosis and 66 with liver cirrhosis). Liver biopsy was performed on 56 of 109 enrolled patients...
April 19, 2024: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://read.qxmd.com/read/38643245/increased-prevalence-but-decreased-survival-of-nonviral-hepatocellular-carcinoma-compared-to-viral-hepatocellular-carcinoma-in-recent-ten-years
#16
JOURNAL ARTICLE
Ting-Chun Chen, Shun-Wen Hsiao, Yang-Yuan Chen, Hsu-Heng Yen, Wei-Wen Su, Yu-Chun Hsu, Siou-Ping Huang, Pei-Yuan Su
Due to the comprehensive hepatitis B virus vaccination program in Taiwan since 1986, the development of antiviral therapy for chronic hepatitis B and chronic hepatitis C infection and covered by National health insurance. Besides, the increased prevalence of nonalcoholic fatty liver disease (NAFLD) and currently, approved therapy for NAFLD remain developing. The etiology of liver-related diseases such as cirrhosis and hepatocellular carcinoma required reinterpretation. This study aimed to analyze the incidence and outcome of hepatocellular carcinoma (HCC) due to viral (hepatitis B and hepatitis C) infection compared to that of nonviral etiology...
April 20, 2024: Scientific Reports
https://read.qxmd.com/read/38642564/pathophysiology-and-therapeutic-options-for-cirrhotic-portal-hypertension
#17
REVIEW
Sergi Guixé-Muntet, Sergio Quesada-Vázquez, Jordi Gracia-Sancho
Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy. Portal hypertension occurs due to increased resistance of the cirrhotic liver vasculature to portal blood flow and is further aggravated by the hyperdynamic circulatory syndrome. Existing knowledge indicates that the profibrogenic phenotype acquired by sinusoidal cells is the initial factor leading to increased hepatic vascular tone and fibrosis, which cause increased vascular resistance and portal hypertension...
April 17, 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38641427/factor-modification-in-the-association-between-high-density-lipoprotein-cholesterol-and-liver-cancer-risk-in-a-nationwide-cohort
#18
JOURNAL ARTICLE
Su Youn Nam, Junwoo Jo, Won Kee Lee, Chang Min Cho
BACKGROUND/AIMS: The effect modification by smoking and menopausal status in the association between high-density lipoprotein cholesterol (HDL-C) and liver cancer risk has not been reported. METHODS: This population-based cohort study included 4.486 million cancer-free individuals among those who underwent national cancer screening in 2010 and were followed up until December 2017. We conducted analyses in populations that excluded people with chronic hepatitis B, chronic hepatitis C and liver cirrhosis (Model I) and that included those diseases (Model III)...
April 11, 2024: International Journal of Epidemiology
https://read.qxmd.com/read/38641047/exploring-the-potential-of-drug-repurposing-for-liver-diseases-a-comprehensive-study
#19
REVIEW
Fares E M Ali, Mustafa Ahmed Abdel-Reheim, Emad H M Hassanein, Mostafa K Abd El-Aziz, Hanan S Althagafy, Khalid S A Badran
Drug repurposing involves the investigation of existing drugs for new indications. It offers a great opportunity to quickly identify a new drug candidate at a lower cost than novel discovery and development. Despite the importance and potential role of drug repurposing, there is no specific definition that healthcare providers and the World Health Organization credit. Unfortunately, many similar and interchangeable concepts are being used in the literature, making it difficult to collect and analyze uniform data on repurposed drugs...
April 17, 2024: Life Sciences
https://read.qxmd.com/read/38638786/a-case-of-idiopathic-portal-hypertension-diagnosed-by-noninvasive-fibrosis-evaluation-using-elastography
#20
Rie Yano, Tomoko Tadokoro, Asahiro Morishita, Emi Ibuki, Tsutomu Masaki
Idiopathic portal hypertension (IPH) is often misdiagnosed as liver cirrhosis. Because it is difficult to distinguish between the two using diagnostic imaging, invasive tests, such as pathology and hepatic vein pressure gradient measurement, are necessary to make a diagnosis. Several studies have shown that the measurement of liver and spleen stiffnesses using elastography is useful in the diagnosis of IPH; however, there are few concrete reports on this subject. Herein, we report the case of a 58-year-old woman with IPH in which elastography was helpful for the diagnosis...
March 2024: Curēus
keyword
keyword
24180
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.